This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Paul Baverel: Innovator in Dermatological Treatments
Introduction
Paul Baverel is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of dermatology, particularly in the treatment of atopic dermatitis. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Paul Baverel holds 1 patent for his invention titled "Methods for treating atopic dermatitis and related disorders." This patent focuses on utilizing an interleukin-13 (IL-13) binding protein, such as an anti-IL-13 antibody or an IL-13-binding fragment, to treat atopic dermatitis and related disorders effectively.
Career Highlights
Baverel is currently associated with MedImmune Limited, a leading biotechnology company. His work at MedImmune has allowed him to explore and develop innovative treatments that address pressing medical needs in dermatology.
Collaborations
Throughout his career, Paul has collaborated with esteemed colleagues, including Gene Colice and Rene Van Der Merwe. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking treatments.
Conclusion
Paul Baverel's contributions to the field of dermatology through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to make a significant impact on the treatment of atopic dermatitis and related disorders.